Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.

Molecular Carcinogenesis
Sanjeev Shukla, Sanjay Gupta

Abstract

Deregulation of insulin-like growth factor (IGF)-I/IGF-IR signaling has been implicated in the development and progression of prostate cancer. Agents that can suppress the mitogenic activity of the IGF/IGF-IR growth axis may be of preventive or therapeutic value. We have previously demonstrated that apigenin, a plant flavone, modulates IGF signaling through upregulation of IGFBP-3. In this study, we investigated the mechanism(s) of apigenin action on the IGF/IGF-IR signaling pathway. Exposure of human prostate cancer DU145 cells to apigenin markedly reduced IGF-I-stimulated cell proliferation and induced apoptosis. Apigenin inhibited IGF-I-induced activation of IGF-IR and Akt in DU145 cells. Similar growth inhibitory and apoptotic responses were observed in PC-3 cells, which constitutively overexpress this pathway. This effect of apigenin appears to be due partially to reduced autophosphorylation of IGF-IR. Inhibition of p-Akt by apigenin resulted in decreased phosphorylation of GSK-3beta along with decreased expression of cyclin D1 and increased expression of p27/kip1. In vivo administration of apigenin to PC-3 tumor xenografts inhibited tumor growth, resulted in IGF-IR inactivation and dephosphorylation of Akt and its downstr...Continue Reading

References

Sep 1, 1989·Journal of Natural Products·R L GeahlenD E Pratt
Feb 1, 1995·Endocrine Reviews·J I Jones, D R Clemmons
Jan 1, 1995·Progress in Growth Factor Research·B TönshoffO Mehls
Jun 24, 1998·Journal of the National Cancer Institute·A WolkD Trichopoulos
Jul 9, 1999·The Journal of Pathology·P L FernándezA Cardesa
Oct 29, 1999·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·P C Hollman, M B Katan
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I K WangJ K Lin
Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·J DiGiovanniC Conti
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·S CaltagironeM Piantelli
Sep 21, 2000·Journal of the National Cancer Institute·H Yu, T Rohan
Sep 12, 2001·World Journal of Urology·B DjavanM Marberger
Jun 11, 2002·Annual Review of Nutrition·Julie A Ross, Christine M Kasum
Aug 11, 2004·Experimental Cell Research·Franc LlorensEmilio Itarte
Mar 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jing FangBing-Hua Jiang
Mar 24, 2005·Journal of Cellular and Molecular Medicine·Gang SongShideng Bao
Sep 10, 2005·Reviews in Endocrine & Metabolic Disorders·J M PellA Drozd
Oct 19, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sanjeev ShuklaSanjay Gupta
Dec 24, 2005·Advances in Experimental Medicine and Biology·Josef V Silha, Liam J Murphy
May 2, 2006·Molecular Cancer Therapeutics·Sanjeev Shukla, Sanjay Gupta
Sep 13, 2006·Archives of Pharmacal Research·Avanthika GopalakrishnanAh-Ng Tony Kong
Dec 5, 2006·International Journal of Oncology·Deendayal PatelSanjay Gupta
Jun 7, 2007·International Journal of Cancer. Journal International Du Cancer·Sanjeev ShuklaSanjay Gupta
Nov 21, 2007·Cellular Signalling·Fumi Takahashi-Yanaga, Toshiyuki Sasaguri

❮ Previous
Next ❯

Citations

Mar 23, 2010·Pharmaceutical Research·Sanjeev Shukla, Sanjay Gupta
Oct 12, 2010·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Laura BicaPaul S Donnelly
Jul 22, 2010·FEBS Letters·Ichiro KawasakiYhong-Hee Shim
Sep 21, 2010·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Jing CaiShu-Hui Zhang
Jan 21, 2014·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Hollie I SwansonJoseph Valentino
May 30, 2014·European Journal of Drug Metabolism and Pharmacokinetics·K Kishore KumarS Sujatha
Jul 6, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Shan-Qing ZhengHuai-Rong Luo
Jul 28, 2016·European Journal of Medicinal Chemistry·Guojun PanPeng Yu
Jan 18, 2017·Nutrition and Cancer·Wissam Zam, Aziz Khadour
Feb 7, 2018·Journal of Zhejiang University. Science. B·Xavier-Ravi BaskaranWen-Bo Liao
Feb 15, 2020·Phytotherapy Research : PTR·Muhammad ImranJavad Sharifi-Rad
May 19, 2009·FEBS Letters·Zhao-dong LiJing Fang
Oct 6, 2015·Oncotarget·Sanjeev ShuklaSanjay Gupta
May 31, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Meenakshi Sudhakaran, Andrea I Doseff
Dec 18, 2020·Life Sciences·Semim Akhtar AhmedAjaikumar B Kunnumakkara
Apr 20, 2020·Medical Hypotheses·Mark F McCartyLidianys Lewis Lujan

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis